Vascular BioSciences (VBS) is a biopharmaceutical and medical device company focused on cardiovascular and inflammatory diseases. It offers interventional catheters to obtain pulmonary endoarterial biopsies, provides molecular diagnostic solutions, and develops targeted therapies. Its lead therapeutic candidate is aimed at the treatment of pulmonary hypertension and sepsis patients.